Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan-augmented Behavioural Activation in Anhedonia
NCT07017023Phase 1Recruiting
- Sponsor
- University of Oxford
- Start
- Jul 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in anhedonia ((none)) comparing Losartan + BA with Placebo + BA (2 arms). Primary endpoint: Change in reinforcement learning at 7 days. Started Jul 2025; status: recruiting.
02
Drugs
losartan
03
Conditions
anhedonia ((none))
Beyond the preview
Go deeper on NCT07017023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07017023.